Invention Grant
- Patent Title: Protein P8 derived from lactic acid bacteria and its use as anti-cancer agent
-
Application No.: US16303208Application Date: 2017-02-15
-
Publication No.: US11213565B2Publication Date: 2022-01-04
- Inventor: Myung Jun Chung
- Applicant: CELL BIOTECH CO., LTD.
- Applicant Address: KR Gyeonggi-do
- Assignee: CELL BIOTECH CO., LTD.
- Current Assignee: CELL BIOTECH CO., LTD.
- Current Assignee Address: KR Gyeonggi-do
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: KR10-2016-0159479 20161128
- International Application: PCT/KR2017/001625 WO 20170215
- International Announcement: WO2018/097402 WO 20180531
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P35/00 ; A61K38/16 ; A61K35/744 ; A23L33/18 ; C07K14/335 ; C12N15/74 ; A61K35/00
Abstract:
The present invention relates to a protein derived from lactic acid bacteria and a method for producing the same. The lactic acid bacteria-derived protein of the present invention is a purified protein isolated from lactic acid bacteria (Lactobacillus rhamnosus) having an excellent therapeutic effect against colorectal cancer. It has been demonstrated to have a remarkable effect against colorectal diseases, and thus is expected to be widely used as a natural protein therapeutic agent against colorectal diseases in the medical field.
Public/Granted literature
- US20190201481A1 PROTEIN P8 DERIVED FROM LACTIC ACID BACTERIA AND ITS USE AS ANTI-CANCER AGENT Public/Granted day:2019-07-04
Information query
IPC分类:
